Vulnerable plaque: scope of the problem.
Wilensky
Robert L
RL
PENN Laboratory of Preclinical Cardiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. robert.wilensky@uphs.upenn.edu
D000792:Angiography / Q000379:methods; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D050197:Atherosclerosis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018084:Ultrasonography, Interventional
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors